These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cytomegalovirus infection in organ transplant recipients. Hibberd PL; Snydman DR Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770 [TBL] [Abstract][Full Text] [Related]
12. [Perspectives of immunosuppressive therapy]. Meuer S; Sido B; Dengler T Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens. You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120 [TBL] [Abstract][Full Text] [Related]
14. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471 [TBL] [Abstract][Full Text] [Related]
15. Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection. van den Berg AP; van Son WJ; Tegzess AM; The TH Transplant Proc; 1993 Feb; 25(1 Pt 2):1419-20. PubMed ID: 7680157 [No Abstract] [Full Text] [Related]
16. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation. Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172 [TBL] [Abstract][Full Text] [Related]